GLMD
Galmed Pharmaceuticals Ltd
NASDAQ: GLMD · HEALTHCARE · BIOTECHNOLOGY
$0.56
-4.92% today
Updated 2026-04-29
Market cap
$4.12M
P/E ratio
—
P/S ratio
61.38x
EPS (TTM)
$-2.39
Dividend yield
—
52W range
$0 – $2
Volume
3.7M
Galmed Pharmaceuticals Ltd (GLMD) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.08M | $-2.52M | $-9.24M | $-8.47M | $-12.13M | $-12.07M | $-9.02M | $-14.94M | $-26.29M | $-32.89M | $-18.50M | $-6.14M | $-5.88M | $-6.32M |
| Capital expenditures | $32000.00 | $13000.00 | $770000.00 | $159000.00 | $17000.00 | $21000.00 | $90000.00 | $12000.00 | $44000.00 | $11000.00 | $4000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | $5000.00 | $4000.00 | $9000.00 | $50000.00 | $169000.00 | $239000.00 | $387000.00 | $35000.00 | $39000.00 | $42000.00 | $35000.00 | $31000.00 | $83000.00 | — |
| Stock-based comp | $208000.00 | $10.85M | $601000.00 | $970000.00 | $1.63M | $1.39M | $1.78M | $2.23M | $2.07M | $1.89M | $1.30M | $892000.00 | $531000.00 | $546000.00 |
| Free cash flow | $-3.11M | $-2.54M | $-10.01M | $-8.63M | $-12.15M | $-12.09M | $-9.11M | $-14.95M | $-26.33M | $-32.90M | $-18.50M | $-6.14M | $-5.88M | $-6.32M |
| Investing cash flow | $-32000.00 | $3000.00 | $-9.02M | $-11.11M | $6.34M | $6.44M | $-60.02M | $6.68M | $16.54M | $11.46M | $17.56M | $800000.00 | $-1.11M | — |
| Financing cash flow | $3.68M | $1.94M | $41.86M | $4.73M | $4.73M | $15.55M | $80.18M | $143000.00 | $768000.00 | $17.37M | $70000.00 | $6.18M | $8.79M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |